MODULATION OF PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE (PAF-AH) ACTIVITY IN MONOCYTES MACROPHAGES BY ADHERENT PLATELETS

被引：0
|
作者：
KRAUSE, S
PENNEWITZ, A
FINKELBERG, L
RUSSWURM, S
PIPY, B
LOSCHE, W
机构：
[1] FRIEDRICH SCHILLER UNIV,CTR VASC BIOL & MED ERFURT,O-6900 JENA,GERMANY
[2] CHU RANGUEIL,INSERM,CJF9107,F-31054 TOULOUSE,FRANCE
来源：
THROMBOSIS AND HAEMOSTASIS | 1995年 / 73卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1089 / 1089
页数：1
相关论文
共 50 条
  • [21] Platelet Activating Factor Acetylhydrolase (PAF-AH) Activity: Could It Have a Role on Coagulation in Covid-19 Patients?
    Bayrak, Tulin
    Sener, Gulsen
    Gokmen, Emel Saglam
    Bayrak, Ahmet
    CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, 2023, 13 (03): : 503 - 510
  • [22] Glycaemic control reduces the platelet-activating factor acetylhydrolase activity (PAF-AH activity) in type 2 diabetes mellitus
    Cubero, J.
    Vinagre, I.
    Sanchez-Quesada, J.
    Sanchez-Hernandez, J.
    Santos, L.
    Blanco-Vaca, F.
    Ordonez-Llanos, J.
    Perez, A.
    DIABETOLOGIA, 2009, 52 : S521 - S521
  • [23] Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)
    Diana M. Stafforini
    Cardiovascular Drugs and Therapy, 2009, 23 : 73 - 83
  • [24] STUDY OF PLATELET-ACTIVATING-FACTOR (PAF) LEVELS AND PAF ACETYLHYDROLASE (AH) ACTIVITIES IN PATIENTS WITH PRIMARY GLOMERULONEPHRITIS (PGN)
    IATROU, C
    MOUSTAKAS, G
    ANTONOPOULOU, S
    DEMOPOULOS, CA
    ZIROGIANNIS, P
    JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1994, 10 (1-2): : 117 - 118
  • [25] SHEEP PLATELETS AND PLATELET-ACTIVATING-FACTOR (PAF)
    VANDERZEE, H
    MOON, DG
    KRASODOMSKI, J
    KAPLAN, JE
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 1041 - 1041
  • [26] Implication of PAF and acetylhydrolase (PAF-AH) activity in periodontal disease
    Baltas, G
    Kotsifaki, H
    Antonopoulou, S
    Kipioti, A
    Demopoulos, CA
    PLATELET-ACTIVATING FACTOR AND RELATED LIPID MEDIATORS 2: ROLES IN HEALTH AND DISEASE, 1996, 416 : 135 - 141
  • [27] MODIFICATION OF LOW-DENSITY-LIPOPROTEIN BY COCULTURES OF HUMAN AORTIC-WALL CELLS IS MODULATED BY PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE (PAF-AH)
    NAVAB, M
    HAMA, SY
    STAFFORINI, DM
    PRESCOTT, SM
    MCINTYRE, TM
    FOGELMAN, AM
    CIRCULATION, 1993, 88 (04) : 561 - 561
  • [28] Measurement of plasma platelet-activating factor acetylhydrolase (PAF-AH) concentrations in hyperlipidemia and diabetes by sandwich ELISA
    Kujiraoka, T
    Ishihara, M
    Iwasaki, T
    Ito, M
    Kawaguchi, A
    Tsuji, M
    Ishii, J
    Egashira, T
    Miller, NE
    Hattori, H
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 329 - 329
  • [29] A spectrophotometric assay for serum platelet-activating factor acetylhydrolase (PAF-AH) and its activity on healthy men and women.
    Kosaka, T
    Soda, Y
    Yamaguchi, M
    Kishimoto, T
    Miyanaga, K
    Mizuno, K
    CLINICAL CHEMISTRY, 2000, 46 (06) : A176 - A176
  • [30] Bacterial Clearance Is Improved in Septic Mice by Platelet-Activating Factor-Acetylhydrolase (PAF-AH) Administration
    Teixeira-da-Cunha, Mariana G. A.
    Gomes, Rachel N.
    Roehrs, Nathassia
    Bozza, Fernando A.
    Prescott, Stephen M.
    Stafforini, Diana
    Zimmerman, Guy A.
    Bozza, Patricia T.
    Castro-Faria-Neto, Hugo C.
    PLOS ONE, 2013, 8 (09):
12345